In humans, piperazine citrate serves a similar function and is used to treat pinworm and roundworm infestations in adults and children. The drug acts by paralyzing the muscles of mature worms and dislodging them from the walls of the intestines. TFMPP is controlled in Texas under Penalty Group 2, as a hallucinogenic substance.
Toxic Effects
At high doses, piperazines may produce hallucinations, convulsions, and slowed breathing that can result in death. The physical effects of piperazine use include nausea, vomiting, redness of the skin, stomach pains, thirst, dry mouth, frequent urination, bladder infection or irritation, severe headaches, and “hangover” feelings lasting up to two days. BZP and TFMPP also affect brain centers that control movement. Muscle stiffness, uncontrollable shaking, jaw clenching, and nervous tics may occur in users. In late 2004 and early 2005, it was being sold over-the-counter in New Zealand as an herbal party pill.
Is It Dangerous To Mix With Other Drugs?
There is no sure way of knowing the exact dose of BZP and/or TFMPP in tablet form because all of the pills are made in illegal labs. Frequent users usually take anywhere from 35 milligrams to 150 milligrams at a time. BZP itself was initially developed as a potential antidepressant drug, but was found to have similar properties to amphetamine and therefore liable to abuse. In the 1980s, it was used in Hungary to manufacture piberaline, a substance marketed as an antidepressant, but later withdrawn 2.
In recent years, the number of new psychoactive substances (NPS) appearing on the illicit drug market strongly increased. However, little is known about their toxic effects and risks. Therefore, we determined the most frequently occurring NPS in The Netherlands and combined this with data regarding drug-related intoxications. Data from the Drugs Information and Monitoring System (DIMS) and the Dutch Poisons Information Centre (DPIC) were combined and jointly analyzed. The number of drug samples submitted to DIMS for analysis containing NPS increased from 22 in 2007 to 431 samples in 2013.
(Oddly enough, the pills contain no herbs.) The staff of New Zealand’s Christchurch Hospital, according to a New Zealand Press article, said that piperazine users admitted for emergency treatment “were usually young women in their late teens or early twenties.” BZP + TFMPP – these two substances seem to work synergistically in the central nervous system. Even at low doses, they increase levels of serotonin and dopamine parallel to each other mimicking the effects seen in MDMA.
- A range of other piperazine derivatives have also been sold as ingredients in party pills, and many of these branded “proprietary blends” have subsequently been sold in countries around the world.
- In the United States, the Controlled Substances Act (CSA) of 1970 called for the assignment of all controlled drug substances into one of five categories called schedules.
- In the late 1990s, BZP emerged in New Zealand as a ‘legal alternative’ for MDMA and methamphetamine 3.
- However, despite estimates of over 20 million doses sold in New Zealand alone and increasing seizures by the Drug Enforcement Administration in the USA, there are no published cases of dependence worldwide.
- Methods The inhibitory effects of seven benzyl and phenyl piperazines were measured in microsomal incubation assays of probe substrates for five major CYP isoenzymes.
- BZP + TFMPP – these two substances seem to work synergistically in the central nervous system.
Typical Users
Parasites are organisms that must live with, in, or on other organisms to survive. The stimulant effects of piperazines are similar to MDMA (ecstasy) but dose for dose they are not as potent. (2007), ‘Legal piperazine-containing party pills – a new trend in substance misuse’, Drug and Alcohol Review, Volume 26, No 3, pp. 335–343. Baumann, M.H., Clark, R.D., Budzynski, A.G., Partilla, J.S., Blough, B.E.
Use And Effects
The combination of BZP and TFMPP induced similar subjective effects, along with well-characterized dexamphetamineand MDMA-like effects. Background This study aimed to investigate patterns and context of use of BZP-party pills, function of use, and positive and negative effects experienced by a sample of New Zealand young people who had used the products. Methods A qualitative study comprised of semi-structured interviews and group discussions. Results The sample included 58 young people aged 17–23 years who had used BZP-party pills in the previous 12 months.
This study aimed to explore the potential for drug-drug interactions involving benzylpiperazine (BZP) and trifluoromethylphenylpiperazine (TFMPP). This was achieved by determining the effects of BZP and TFMPP on the metabolism of drugs commonly found in the clinical setting by using pooled human liver microsomes. Incubations consisted of a probe substrate (drug of interest), a potential inhibitor (BZP or TFMPP), a suitable enzyme co-factor (NADPH), and pooled human liver microsomes. Loss of substrate was determined by analysing pre- and post-incubation concentrations in the samples by using HPLC/UV analysis. Both TFMPP and BZP were found to inhibit the metabolism of dextromethorphan, caffeine, and ethinyloestradiol.
The chemical composition of substances sold as piperazines are changing all the time, which is why you can never be sure of what you’re getting and how it could affect you. Neither BZP nor any other piperazines are under international control, although several (BZP, TFMPP, mCPP, MDBP) were pre-reviewed by the WHO Expert Committee on Drug Dependence in 2012. Several countries have introduced national control measures over piperazines. Peters, F.T., Schaefer, S., Staack, R.F., Kraemer, T., Maurer, H.H.
Sought After Effects
Basic pharmacokinetic properties are described for both BZP and TFMPP when taken alone and in combination. Several studies have shown that these drugs cause several drug-drug interactions. Following oral administration of mCPP to healthy human male volunteers, the elimination half-life ranges from 2.6 to 6.1 hours with a wide variation in peak blood levels and bioavailability. The hydroxy metabolites are partly excreted as the corresponding glucuronides and/or sulphates, and the chloroanilines are partly excreted as the acetylated derivatives. Physiological and subjective effects reach their peak 1 to 2 hours after oral administration and can last 4 to 8 hours. The negative effects of mCPP, often typical of a serotonin syndrome, include anxiety, dizziness, confusion, shivering, sensitivity to light and noise, fear of losing control, migraine and panic attacks.
BZP/piperazines Drug Profile
Medical evidence suggests that the drug combination made her extremely thirsty. Before going into a coma, she consumed 10 liters of water in just 15 hours. The young woman experienced high blood pressure and brain swelling prior to her death. At doses of 20 milligrams to 100 milligrams, BZP and TFMPP reportedly produce a range of mental experiences lasting six to eight hours. Amphetamine-like effects include euphoria, alertness, a reduced need for both food and sleep, a heightened sense of touch and other pleasurable sensations, and a sense of emotional closeness with others. At higher doses, though, users have reported stomach pain, vomiting, and feelings of extreme anxiety and paranoia.
Treatment will most likely include psychological counseling. Until March of 2004, piperazines were considered legal in the United States. Piperazines sold in bulk over the Internet made their way to the club and rave scene. They grew in popularity among adolescents and young adults, sometimes being sold as the dangerous and often-abused drug ecstasy but usually as “BZP,” “legal E,” “legal X,” or “A2.” The dangers of BZP and TFMPP stem from their stimulant effects.
- Basic pharmacokinetic properties are described for both BZP and TFMPP when taken alone and in combination.
- When the drug is stopped altogether, a “rebound effect” on the appetite center of the brain may occur, leading to excessive eating and weight gain.
- Potentially risky behaviours identified included taking large doses, mixing BZP-party pills with alcohol and other substances, and driving whilst under the influence of BZP-party pills.
- In the mass spectrum, the principal ions (m/z) of mCPP are 154 (base peak), 196, 156, 56 and 138.
BZP is banned in several countries, including the USA, Republic of Ireland, Australia and New Zealand, but is available on a more or less restricted basis in many jurisdictions. A range of other piperazine derivatives have also been sold as ingredients in party pills, and many of these branded “proprietary blends” have subsequently been sold in countries around the world. Health care providers are seeing an increased number of patients under the influence of several new psychoactive drug classes. Synthetic cannabinoids, cathinones, and piperazines are sought by users for their psychoactive effects, perceived safety profile, minimal legal regulations, and lack of detection on routine urine drug screening. However, these drugs are beginning to be recognized by the medical community for their toxic effects.
Rapid heart rhythms, tremors, and convulsions have been reported in some cases. Benzylpiperazine (BZP) and trifluoromethyl-phenylpiperazine (TFMPP) are both stimulants—substances that increase the activity of a living organism or one of its parts. Neither one of these compounds has any known medical use for humans, at least not in their existing chemical forms. BZP and TFMPP are substances known as intermediaries, meaning they are at a middle stage in chemical production. Because piperazines can dissolve fats, they are often used as cleaning solutions.
Subjective Effects In Humans Following Administration Of Party Pill Drugs BZP And TFMPP Alone And In Combination
Commonly referred to as ‘legal highs’, new psychoactive substances (NPS) are synthetic or naturally occurring substances that mimic the effects of illegal drugs such as cannabis, amphetamines, and ecstasy. Through presenting the results of a cohort study with BZP-party pill users in Aotearoa New Zealand, this article considers the evidence for any ‘displacement effect’ caused by the criminalisation of the drug in 2008. The findings demonstrate that prohibition was only successful insofar as users ceased taking the banned NPS. In contrast to previous research, we found a strong displacement effect following criminalisation with half of the sample increasing their use of other illegal drugs and, for a third, their use of alcohol.
